This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: Santen Pharmaceutical Co., Ltd., Asahi Glass Company, Limited. Active years: 2001-2015.
Company Filing History:
3 out of 282 
1 out of 2,560 
Years Active: 2001-2015
Title: Naruhiro Ishida: Innovator in Retinal Protection
Introduction
Naruhiro Ishida is a notable inventor based in Ikoma, Japan. He has made significant contributions to the field of ophthalmology, particularly in the protection of retinal neuronal cells. With a total of 3 patents, his work has the potential to impact the treatment of various eye diseases.
Latest Patents
Ishida's latest patents include a method for protecting retinal neuronal cells. This method involves administering an effective amount of a prostaglandin F2α derivative to a patient. Additionally, he has developed a method for preventing or treating eye diseases associated with retinal neuronal cell damage through the same therapeutic approach. Another significant patent involves a polypeptide that exhibits water channel activity and its corresponding DNA sequence.
Career Highlights
Throughout his career, Naruhiro Ishida has worked with prominent companies such as Santen Pharmaceutical Co., Ltd. and Asahi Glass Company, Limited. His experience in these organizations has allowed him to refine his expertise in the field of eye health and contribute to innovative solutions.
Collaborations
Ishida has collaborated with notable colleagues, including Kousaku Okubo and Hiroshi Kuriyama. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Naruhiro Ishida's contributions to the field of ophthalmology through his innovative patents demonstrate his commitment to improving eye health. His work continues to pave the way for new treatments and therapies that can benefit patients worldwide.